What's better than momentum? Mo' momentum. Let's take a closer look at five of this past week's biggest scorchers.


Dec. 7

Weekly Gain

My Watchlist

Life Partners Holdings (NASDAQ: LPHI)




SandRidge Energy (NYSE: SD)




Cyclacel Pharmaceuticals (NASDAQ:CYCC)








First Solar (NASDAQ:FSLR)




Source: Barron's.

Life Partners Holdings was Nasdaq's biggest winner, soaring 30% after announcing its quarterly dividend. There may seem to be nothing special about a routine payout of $0.10 a share, but the life settlements pioneer is currently yielding 13%. Sustaining its chunky yield is going to make news.

Shares of SandRidge Energy moved higher on buyout chatter. Two of the largest investors in the emerging oil and gas junior -- Mount Kellett Capital Management and TPG-Axon Capital -- are publicly rallying for an outright sale of the company.

Cyclacel Pharmaceuticals rallied after the biotech developing oral therapies announced that it will update its Phase 3 clinical trial results for its promising treatment of elderly patients with newly diagnosed acute myeloid leukemia. The update will come during a poster presentation at the 54th Annual Meeting of the American Society of Hematology.

Groupon was having a bad week until spiking 23% higher on Friday. The daily-deals leader moved higher on a seemingly baseless rumor that it was about to be acquired by Google (NASDAQ:GOOGL).

Finally, First Solar shined its way to a double-digit gain after announcing that it will open its first demonstration plant in China early next year. Showcasing its solar panels in the world's most populous nation should help increase awareness and demand.

More winners for you
It was a great week for these five stocks. If you want to get an early read on some of tomorrow's major gainers, there's a special report on three hidden winners in a booming industry. The report is free, just like this article, but it won't be around forever, so click here to check it out now.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium advisory service. We’re motley! Questioning an investing thesis -- even one of our own -- helps us all think critically about investing and make decisions that help us become smarter, happier, and richer.